Wed, 25 Nov 2020 12:00:00 EST Effects of Physical Activity in Patients With Diabetes Conditions: Diabetes Mellitus; PreDiabetes Interventions: Other: physical activity counseiling +pilates exercise group; Behavioral: physical activity counseiling group Sponsor: Istanbul University-Cerrahpasa Active, not recruiting
Wed, 25 Nov 2020 12:00:00 EST PoliCOV19-Serosurvey Conditions: SARS-CoV Infection; Volunteers; Healthy Interventions: Diagnostic Test: Blood sampling; Other: Online Questionnaire Sponsors: University of Bern; Interregionale Blutspende SRK Bern Not yet recruiting
Wed, 25 Nov 2020 12:00:00 EST Acute Pancreatitis and Thrombosis (PATHRO) Conditions: Acute Necrotizing Pancreatitis; Portosplenomesenteric Venous Thrombosis Intervention: Other: observational study Sponsor: Nantes University Hospital Not yet recruiting
Tue, 24 Nov 2020 12:00:00 EST Circadian Clocks and Eating Patterns (Cohort) Conditions: Postpartum Women; Diabetes, Gestational Intervention: Sponsor: University of Lausanne Hospitals Recruiting
Tue, 24 Nov 2020 12:00:00 EST Comorbidities and Coinfections in Latent TB Conditions: Latent Tuberculosis; Diabete Mellitus; Malnutrition; Helminth Infection Intervention: Sponsors: Tuberculosis Research Centre, India; National Institutes of Health (NIH) Not yet recruiting
Tue, 24 Nov 2020 12:00:00 EST Effect of Empagliflozin on Liver Fat in Non-diabetic Patients Condition: Non-alcoholic Fatty Liver Disease Interventions: Drug: Empagliflozin 10 MG; Drug: Placebo pills Sponsors: The University of Hong Kong; Food and Health Bureau, Hong Kong Not yet recruiting
Tue, 24 Nov 2020 12:00:00 EST Personalized Nutrition Advice for Optimizing Dietary Habits and Metabolic Status Conditions: Personalized Nutrition; Health Status; Dietary Habits Interventions: Other: Personalized nutrition group; Other: Personalized Plan group; Other: Control group Sponsors: Technological Centre of Nutrition and Health, Spain; Eurecat; Hospital Universitari Sant Joan de Reus; Universitat Rovira i Virgili; Horizon 2020 - European Commission Not yet recruiting
Tue, 24 Nov 2020 12:00:00 EST Study to Assess the Efficacy and Safety of iNCDSS in Type 2 Diabetes Mellitus Patients Condition: Type 2 Diabetes Interventions: Drug: iNCDSS based insulin regime; Drug: routine insulin treatment regime Sponsors: Shanghai Zhongshan Hospital; Shanghai Fifth People's Hospital; Shanghai Xuhui Central Hospital; Shanghai Qingpu Central Hospital Not yet recruiting
Tue, 24 Nov 2020 12:00:00 EST The Impact of ERAS Program in Cardiac Surgery on Patient Prognosis Condition: ERAS Interventions: Other: Nutrition; Other: Control Blood Glucose; Drug: Fasting; Behavioral: Smoking and Alcohol; Other: Control Anemia; Other: Blood Transfusion; Other: GDFT; Other: Remove the tracheal tube; Behavioral: Eating and Drinking; Other: Prevent Thrombosis Sponsor: Shanghai Zhongshan Hospital Not yet recruiting
Tue, 24 Nov 2020 12:00:00 EST
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.
Latest Top (10) News
Coronavirus (COVID-19) Update: FDA Issues New Policy on Dry Heat for Reuse of Certain Respirators The FDA issued guidance on the use of dry heat for bioburden reduction to help support the single-user reuse of certain particulate filtering facepiece respirators (FFRs), such as N95 respirators, by health care personnel when there is a limited supply during the COVID-19 public health emergency.
Tue, 24 Nov 2020 18:13:56 EST FDA Approves First Drug to Treat Rare Metabolic Disorder Today, the FDA approved the first treatment for primary hyperoxaluria type 1 (PH1), a rare genetic disorder which causes recurrent kidney stones and loss of kidney function.
Mon, 23 Nov 2020 17:57:16 EST FDA Expands Approval of Influenza Treatment to Post-Exposure Prevention Today, the FDA expanded the approved indication for Xofluza (baloxavir marboxil) to include post-exposure prevention of influenza (flu) for patients 12 years of age and older after contact with an individual who has the flu.
Fri, 20 Nov 2020 16:54:25 EST Coronavirus (COVID-19) Update: FDA Authorizes Drug Combination for Treatment of COVID-19 Today, the FDA issued an emergency use authorization for the drug baricitinib, in combination with remdesivir, for the treatment of COVID-19 in hospitalized adults and pediatric patients 2+ years requiring supplemental oxygen, invasive mechanical ventilation, or ECMO.
Thu, 19 Nov 2020 16:26:45 EST
Diabetes news from the American Diabetes Association
